Volume 26, Issue 6 (9-2019)
RJMS 2019, 26(6): 25-32 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Baghbani-Arani F, Shirkavand A. association between ERCC2 c.2251A>C polymorphism and risk of colorectal cancer in Iran population. RJMS 2019; 26 (6) :25-32
URL: http://rjms.iums.ac.ir/article-1-5567-en.html
URL: http://rjms.iums.ac.ir/article-1-5567-en.html
Department of Genetics & biotechnology, School of Biological Science, Varamin-Pishva branch, Islamic Azad University, Varamin, Iran , baghbani.f@gmail.com
Abstract: (2572 Views)
Background: The excision repair cross-complementing group 2 (ERCC2 (is a Nucleotide Excision Repair (NER) gene. The ERCC2 c.2251A>C Polymorphism is located in codon 751 of exon 23 which result in amino acid changes (Lys751Gln) in the ERCC2. This Polymorphism is associated with decreased DNA repair capacity cause to genetic instability and carcinogenesis. Thus, we examined the associations between ERCC2 c.2251A>C Polymorphism and sporadic colorectal cancer in Iranian population.
Methods: In this case-control study, 291 incident sporadic colorectal cancer cases and 140 controls were analyzed. ERCC2 Genotyping was done using a polymerase chain reaction restriction fragment length poly-morphism (PCR-RFLP).
Results: Genotype frequency of c.2251A>C in ERCC2 in patients and healthy groups was significantly different (p<0.05). The results indicated that the mutant allele (C) can increased significantly risk of colorectal cancer (OR: 1.37; 95% CI: 1.03-1.83). Also, In ERCC2 genotypes, the CC genotype led to an increase in risk of colorectal cancer (OR: 2.37; 95% CI: 1.03-5.48).
Conclusion: According to the Our results the ERCC2 c.2251A>C Polymorphism involved in colorectal cancer susceptibility in Iranian population.
Methods: In this case-control study, 291 incident sporadic colorectal cancer cases and 140 controls were analyzed. ERCC2 Genotyping was done using a polymerase chain reaction restriction fragment length poly-morphism (PCR-RFLP).
Results: Genotype frequency of c.2251A>C in ERCC2 in patients and healthy groups was significantly different (p<0.05). The results indicated that the mutant allele (C) can increased significantly risk of colorectal cancer (OR: 1.37; 95% CI: 1.03-1.83). Also, In ERCC2 genotypes, the CC genotype led to an increase in risk of colorectal cancer (OR: 2.37; 95% CI: 1.03-5.48).
Conclusion: According to the Our results the ERCC2 c.2251A>C Polymorphism involved in colorectal cancer susceptibility in Iranian population.
References
1. 1. Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics. CA Cancer J Clin; 2014.64(2):104-17.
2. 2.Vogelstein B, Kinzler KW. The genetic basic human cancer. 2nd ed. New York: McGraw-Hill. Professional; 2002.
3. 3.Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature; 2001.411(6835): 366-74.
4. 4. Christmann M .Tomicic M. Wynand P. Bernd Kaina R. Mechanisms of human DNA repair: an update. Toxicology; 2003.193 (1–2):3-3.
5. 5. Stuart G. Clarkson, Richard D. Wood. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: An appraisal. DNA Repair; 2005.5(10) 1068-1074.
6. 6. Wu KG, He X, Li YH, Xie WB, Huang X. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case–control studies, Tumor Biol; 2014. 35:11243-11259.
7. 7. Yin QH, Liu C, Hu JB, Meng RR, Li L, Wang YJ. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev; 2013.14(1):231-6.
8. 8. Duan XL, Gong H, Zeng XT, Ni XB, Yan Y, Chen W, et al. Association between XPD Asp312Asn Polymorphism and Esophageal Cancer Susceptibility: A Meta-analysis. Asian Pacific J Cancer Prev; 2012.13: 3299-3303.
9. 9. Karam RA. DNA repair genes polymorphisms and risk of colorectal cancer in Saudi patients. Arab J Gastroenterol; 2016.17(3):117-120.
10. 10. Park DJ, Stoehlmacher j, Zhang w, Tsao-Wei DD, Groshen S, et.al. A Xeroderma Pigmentosum Group D Gene Polymorphism Predicts Clinical Outcome to Platinum-based Chemotherapy in Patients with Advanced Colorectal Cancer. Cancer Res; 2001.61:8654-8.
11. 11. Jelonek K, Gdowicz-Kłosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet; 2010. 51:343-352.
12. 12. Loghin A, Bănescu C, Nechifor-Boila A, Chibelean C, Orsolya M, Nechifor-Boila A, et al. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma. Cancer Biomark; 2016.16(2):211-7
13. 13. Sliwinski R, Krupa M, Wisniewska-Jarosinska J, Lech Z, Morawiec J, Chojnacki J B. No association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population. Exp Oncol; 2008. 30: 253-254.
14. 14. Skjelbred M, Sæbø H, Wallin BA, Nexø PC, Hagen IMB, et al. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer; 2006.6: 67-76.
15. 15. Nissar B, Kadla SA, Khan NS, Shah IA, Majid M, Afshan FU, et al. DNA Repair Gene XRCC1 and XPD Polymorphisms and Gastric Cancer Risk: A Case-Control Study Outcome from Kashmir, India. Anal Cell Pathol (Amst); 2018. 26;2018.
16. 16. Rezaei H, Motovali-Bashi M, Khodadad K, Elahi A, Emami H, Naddaffnia H. Relationship between XPD Lys 751 Gln polymorphism and
17. colorectal cancer risk: a case-control study in a population-based study. Gastroenterol Hepatol Bed Bench; 2013. 6: 18-28.
18. 17. Procopciuc LM, Osian G. Interaction between lifestyle factors and the XRCC1, XPD, and XRCC3 genetic variations modulates the risk for sporadic colorectal cancer. Rev Romana Med Lab; 2014. 22:129-141.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
